A detailed history of Cullen/Frost Bankers, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 49,121 shares of ZTS stock, worth $8.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
49,121
Previous 56,582 13.19%
Holding current value
$8.6 Million
Previous $9.81 Million 2.16%
% of portfolio
0.13%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$172.58 - $196.48 $1.29 Million - $1.47 Million
-7,461 Reduced 13.19%
49,121 $9.6 Million
Q2 2024

Aug 05, 2024

SELL
$145.54 - $178.83 $14 Million - $17.2 Million
-96,424 Reduced 63.02%
56,582 $9.81 Million
Q1 2024

May 10, 2024

SELL
$165.67 - $199.94 $844,585 - $1.02 Million
-5,098 Reduced 3.22%
153,006 $25.9 Million
Q4 2023

Feb 06, 2024

SELL
$151.44 - $200.09 $3.48 Million - $4.59 Million
-22,962 Reduced 12.68%
158,104 $31.2 Million
Q3 2023

Nov 02, 2023

SELL
$167.14 - $192.77 $862,609 - $994,885
-5,161 Reduced 2.77%
181,066 $31.5 Million
Q2 2023

Aug 04, 2023

SELL
$160.94 - $186.23 $619,940 - $717,357
-3,852 Reduced 2.03%
186,227 $32.1 Million
Q1 2023

May 05, 2023

SELL
$145.48 - $175.02 $1.03 Million - $1.24 Million
-7,078 Reduced 3.59%
190,079 $31.6 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $814,248 - $977,731
6,209 Added 3.25%
197,157 $28.9 Million
Q3 2022

Nov 07, 2022

SELL
$148.29 - $182.55 $93,126 - $114,641
-628 Reduced 0.33%
190,948 $28.3 Million
Q2 2022

Aug 05, 2022

SELL
$155.97 - $200.09 $840,054 - $1.08 Million
-5,386 Reduced 2.73%
191,576 $32.9 Million
Q1 2022

May 09, 2022

SELL
$181.39 - $234.03 $470,707 - $607,307
-2,595 Reduced 1.3%
196,962 $37.1 Million
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $2.02 Million - $2.58 Million
-10,426 Reduced 4.97%
199,557 $48.7 Million
Q3 2021

Nov 04, 2021

SELL
$189.29 - $209.69 $1.94 Million - $2.15 Million
-10,272 Reduced 4.66%
209,983 $40.8 Million
Q2 2021

Aug 05, 2021

SELL
$155.9 - $187.99 $2.05 Million - $2.48 Million
-13,170 Reduced 5.64%
220,255 $41 Million
Q1 2021

May 05, 2021

SELL
$144.0 - $169.39 $1.99 Million - $2.35 Million
-13,849 Reduced 5.6%
233,425 $36.8 Million
Q4 2020

Feb 08, 2021

SELL
$157.07 - $174.35 $2.37 Million - $2.63 Million
-15,089 Reduced 5.75%
247,274 $40.9 Million
Q3 2020

Nov 05, 2020

SELL
$137.1 - $165.37 $2.16 Million - $2.61 Million
-15,783 Reduced 5.67%
262,363 $43.4 Million
Q2 2020

Aug 05, 2020

BUY
$111.92 - $142.53 $63,346 - $80,671
566 Added 0.2%
278,146 $38.1 Million
Q1 2020

May 01, 2020

SELL
$92.66 - $144.94 $752,955 - $1.18 Million
-8,126 Reduced 2.84%
277,580 $32.7 Million
Q4 2019

Feb 06, 2020

SELL
$116.25 - $133.25 $1.23 Million - $1.41 Million
-10,591 Reduced 3.57%
285,706 $37.8 Million
Q3 2019

Nov 01, 2019

BUY
$112.57 - $128.43 $1.08 Million - $1.23 Million
9,589 Added 3.34%
296,297 $36.9 Million
Q2 2019

Aug 01, 2019

SELL
$97.98 - $114.28 $3.36 Million - $3.92 Million
-34,302 Reduced 10.69%
286,708 $32.5 Million
Q1 2019

Apr 30, 2019

BUY
$81.56 - $100.67 $1.84 Million - $2.27 Million
22,517 Added 7.54%
321,010 $32.3 Million
Q4 2018

Feb 06, 2019

SELL
$79.28 - $95.27 $946,682 - $1.14 Million
-11,941 Reduced 3.85%
298,493 $25.5 Million
Q3 2018

Oct 29, 2018

SELL
$83.5 - $93.23 $3.35 Million - $3.74 Million
-40,098 Reduced 11.44%
310,434 $28.4 Million
Q2 2018

Jul 27, 2018

SELL
$79.9 - $89.2 $1.69 Million - $1.88 Million
-21,112 Reduced 5.68%
350,532 $29.9 Million
Q1 2018

May 11, 2018

BUY
$71.51 - $84.69 $2.74 Million - $3.24 Million
38,315 Added 11.49%
371,644 $31 Million
Q4 2017

Jan 31, 2018

SELL
$63.24 - $72.8 $461,652 - $531,440
-7,300 Reduced 2.14%
333,329 $24 Million
Q3 2017

Nov 02, 2017

BUY
$59.73 - $65.4 $20.3 Million - $22.3 Million
340,629
340,629 $21.7 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.